Overview
Takeda Pharma is a global biopharmaceutical company focused on research and patient needs. It develops treatments for adults with polycythemia vera and narcolepsy type 1, including first-in-class medicines advanced in the company’s laboratories in Shonan.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2026.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2005-02-08. Active
10 1880 0009 0000 0011 0253 2001- 37 1880 0009 0000 0011 0253 2000
- 80 1880 0009 0000 0011 0253 2002
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1.2MPLN 1,163,695 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 19, 2021 | Commercial Companies Code notice | |
| Sep 3, 2020 | Call to creditors | |
| Feb 22, 2019 | Merger registered | |
| Dec 4, 2018 | Merger plan |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 9, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Zarządca Rozliczeń S.A. |
Tenders
1160 tenders recorded as contractor: 142 national ($9,048,831) and 1018 EU ($6,626,131,638).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 15, 2026 | Dostawa różnych środków farmaceutycznych i wyrobów medycznych | –– | Mazowiecki Szpital Specjalistyczny Im.Dr.Józefa Psarskiego w Ostrołęce | |
| Oct 15, 2026 | Dostawa produktów leczniczych oraz leków w ramach programów lekowych | –– | Wojewódzki Szpital Specjalistyczny w Olsztynie | |
| Oct 14, 2026 | Zakup produktów leczniczych, materiałów opatrunkowych, rękawic, wyrobów medycznych, mleka i innych według załączonych 180 pakietów na okres 24 miesięcy | –– | Specjalistyczny Szpital Im. Dra Alfreda Sokołowskiego |
Public sector contracts
Takeda Pharma is the contractor in 161 public sector contracts, worth PLN 177.28m in total. They were signed with 82 public buyers. The largest number (2) were signed with Wojewódzkie Wielospecjalistyczne Centrum Onkologii I Traumatologii Im.M.Kopernika w Łodzi.
| Public buyer | Value | |
|---|---|---|
| Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza w Bydgoszczy | PLN 2,716,875 | |
| Uniwersytecki Szpital Dziecięcy w Lublinie | PLN 4,473 | |
| Podhalański Szpital Specjalistyczny Im. Jana Pawła II w Nowym Targu | PLN 19,186 | |
| Szpital Bielański Im.Ks. Jerzego Popiełuszki Samodzielny Publiczny Zakład Opieki Zdrowotnej | PLN 16,769 | |
| Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie | PLN 38,372 |
Trademarks
Takeda Pharma currently holds no active trademarks with the Polish Patent Office. 9 marks have expired or were not registered. The first mark was filed in 1992.
| Mark | Protected until | |
|---|---|---|
| ONOZIS Beauty(word) | – | |
| ONOZIS(word) | – | |
| MANGANASOL(word) | – | |
| MANGAMAG(word) | – | |
| BEMAG(word) | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
With a multi-member management board: two members of the management board jointly, or a member of the management board jointly with a commercial proxy. With a one-person management board: independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Takeda Pharmaceuticals International Ag | 5,039,804 | $68,068,665.59 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Roche Polskasp. z o.o. | $799,694,562.77 | roche.pl | ||
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.com | ||
| MSD Polska Dystrybucjasp. z o.o. | $341,786,056.16 | msd.pl | ||
| Pfizer Trading Polskasp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| Bristol-Myers Squibb Polskasp. z o.o. | $230,722,737.87 | bms.com | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl | ||
| Glenmark Pharmaceuticalssp. z o.o. | $26,934,644.29 | glenmarkpharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-06-19 | Address change (Ul. Prosta 68, 00-838, Warszawa → Ul. Prosta 28, 00-838, Warszawa) | |
| 2021-03-24 | Share capital change (252,071,250.00 PLN → 63,030,450.00 PLN) | |
| 2020-02-27 | Share capital change (252,071,200.00 PLN → 252,071,250.00 PLN) | |
| 2019-02-01 | Share capital change (251,990,200.00 PLN → 252,071,200.00 PLN) | |
| 2016-07-14 | Address change (Aleje Jerozolimskie 146 A, 02-305, Warszawa → Ul. Prosta 68, 00-838, Warszawa) |
FAQ
Last updated: 2026-10-02